Back to search
FDAFDA · Food and drugs·Recall number D-380-2014

0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Published December 25, 2013 · Recall initiated: July 12, 2013

Summary

FDA records drug Class I recall D-380-2014, published December 25, 2013 and initiated July 12, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 118,100 vials; Lot: Lot # 18-136-DK; Exp. 6/14. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPIVACAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPIVACAINE HYDROCHLORIDE
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot # 18-136-DK; Exp. 6/14
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159-02 recalled?

Yes. FDA published recall D-380-2014 on December 25, 2013. Reported hazard: Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPIVACAINE HYDROCHLORIDE.